Skip to content
HowShorted

Sorrento Therapeutics, Inc. short interest in 2020

In 2020, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 16.47% of shares outstanding on 15 Jan 2020 to 27.99% on 31 Dec 2020, a change of +11.52 percentage points. The year's high was 31.29% on 30 Sep 2020 and its low 11.25% on 15 May 2020, averaging 21.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.55 days on 31 Jan 2020. Full history: Sorrento Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Sorrento Therapeutics, Inc. in 2020

2020 in figures

Start of year
16.47% (15 Jan 2020)
End of year
27.99% (31 Dec 2020)
Change
+11.52 pp
High
31.29% (30 Sep 2020)
Low
11.25% (15 May 2020)
Average
21.31%
Highest days to cover
7.55 (31 Jan 2020)
SEC filings marked
4

Every report in 2020

Sorrento Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202016.47%3.06
31 Jan 202017.84%7.55
14 Feb 202013.56%5.45
28 Feb 202013.13%4.61
13 Mar 202013.60%3.2310-K filed
31 Mar 202013.14%3.48
15 Apr 202013.65%2.78
30 Apr 202011.54%5.54
15 May 202011.25%4.5610-Q filed
29 May 202017.67%1.00
15 Jun 202019.68%1.54
30 Jun 202023.88%2.24
15 Jul 202023.08%2.15
31 Jul 202021.61%2.47
14 Aug 202022.34%1.0010-Q filed
31 Aug 202030.31%1.91
15 Sep 202031.03%3.69
30 Sep 202031.29%1.92
15 Oct 202029.70%4.15
30 Oct 202027.67%6.46
13 Nov 202028.67%5.2810-Q filed
30 Nov 202026.21%4.46
15 Dec 202026.23%6.83
31 Dec 202027.99%4.88

See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.